Payer Wish List For EU Pharma Legislation – Is The European Commission Listening?

At a recent webinar payers and health technology appraisal bodies gave further details on what they want included and left out of the European Commission’s overhaul of the EU pharmaceutical legislation. However, speakers voiced some concerns about whether their demands will be met. 

vector illustration of businessman standing on the edge of ravine thinking before making a decision. describe challenge, risk, obstacles, take a risk and danger.
Evidence requirements to support HTA evaluation should not be seen as an extra obstacle • Source: Shutterstock

More from Market Access

More from Pink Sheet